<DOC>
	<DOCNO>NCT02245165</DOCNO>
	<brief_summary>The aim elucidate NO work conjunction neurotransmitter regulate migrate motility complex ( MMC ) . Twenty-two healthy volunteer undergo water-perfused antroduodenojejunal manometry control period 4 h , follow another 4h bolus injection either saline NO synthase inhibitor NG-monomethyl-L-arginine ( L-NMMA , 10 mg/kg intravenously ) without atropine ( 1 mg ) ondansetron ( 8 mg ) . Effects MMC pattern determine . Exhaled rectal NO monitor throughout experiment . Effects L-NMMA MMC pattern analyze background atropine ondansetron . Blood sample draw analysis simultaneous peptide hormone release bloodstream . Peptide hormone release correlate respective motility pattern elicit LNMMA .</brief_summary>
	<brief_title>Nitric Oxide Control Migrating Motor Complex : L-NMMA Effects Relation Receptor Blockades</brief_title>
	<detailed_description>Dysregulation cyclic motility pattern control propulsion fasting , migrate motor complex ( MMC ) , result small intestinal bacterial overgrowth symptom intestinal obstruction . Nitric oxide ( NO ) act inhibitory neurotransmitter relaxation smooth muscle cell . Little known NO work conjunction neurotransmitter regulate MMC . Methods : Twenty-two healthy volunteer ( 22-38 year ) undergo antroduodenojejunal manometry recording 8h , 4h control period basal motility record 4h bolus injection either saline NO synthase inhibitor NG-monomethyl-L-arginine ( L-NMMA , 10 mg/kg intravenously ) without atropine ( 1 mg ) ondansetron ( 8 mg ) . The effect L-NMMA MMC pattern determine . Exhaled rectal NO monitor throughout experiment mean secure efficient NO synthase inhibition . Expected result : L-NMMA expected increase intestinal motor activity , either direct effect small muscle cell , release motility-stimulating gut peptide hormone ( motility , ghrelin , somatostatin ) . Expected conclusion : A NO donor , nitrite nitrate convert NO acidic milieu stomach may act inhibitor motility . Thus , swallow nitrite nitrate saliva may contribute regulation gastric empty gastrointestinal motility .</detailed_description>
	<mesh_term>Nitric Oxide</mesh_term>
	<mesh_term>omega-N-Methylarginine</mesh_term>
	<criteria>Healthy volunteer 1850 year age Age &lt; 18 , &gt; 50 year Any disease Any medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Nitric oxide</keyword>
	<keyword>Nitric oxide synthase</keyword>
	<keyword>Gastrointestinal motility</keyword>
	<keyword>Gut peptide hormone</keyword>
</DOC>